Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
European Journal of Pharmacology|May 29, 2012
Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in miceRikke Rie Hansen, Arafat Nasser, Sarah Falk, et al.
Behavioural Brain Research|May 26, 2009
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout micePrisca Honore, Diana Donnelly-Roberts, Marian Namovic, et al.
Assay and Drug Development Technologies|March 21, 2012
An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kineticsAndrew M Swensen, Wende Niforatos, Timothy A Vortherms, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2008
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonistsMichael J Morytko, Patrick Betschmann, Kevin Woller, et al.
Journal of Neurophysiology|June 20, 2003
Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVMSteve McGaraughty, Katharine L Chu, Robert S Bitner, et al.
European Journal of Medicinal Chemistry|April 2, 2003
Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitorsGregory A Gfesser, Erol K Bayburt, Marlon Cowart, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonistsWilliam A Carroll, Douglas M Kalvin, Arturo Perez Medrano, et al.
European Journal of Pharmacology|February 1, 2002
Potent desensitization of human P2X3 receptors by diadenosine polyphosphatesHeath A McDonald, Katharine L Chu, Bruce R Bianchi, et al.
Pageof 13